OMNICELL, INC. (NASDAQ:OMCL) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k
-
0

OMNICELL, INC. (NASDAQ:OMCL) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders

On May 23, 2017, Omnicell, Inc. (the Company) held its Annual
Meeting of Stockholders at 2:30 p.m. local time at the Companys
headquarters located at 590 E. Middlefield Road, Mountain View,
California 94043 (the Annual Meeting). As of March 27, 2017, the
Companys record date, there were a total of 37,119,044 shares of
Common Stock outstanding and entitled to vote at the Annual
Meeting. At the Annual Meeting, 35,419,183 shares of Common Stock
were represented in person or by proxy and, therefore, a quorum
was present. Four items of business were acted upon by the
stockholders at the Annual Meeting. The final results for the
votes regarding each proposal are set forth below.
Proposal 1- Election of Directors to Hold Office Until the 2020
Annual Meeting of Stockholders
Ms. Sara J. White and Ms. Joanne B. Bauer were elected to serve
as members of the Companys Board of Directors (the Board) for
three year terms and until their respective successors shall be
elected and qualified or until their earlier resignation or
removal.
Votes were cast as follows for the election of directors:
For
Withheld
Broker Non-Votes
Sara J. White
32,181,439
660,620
2,577,124
Joanne B. Bauer
32,401,791
440,268
2,577,124
Since the Board is divided into three classes with one class
elected each year to hold office for a three-year term, the
following directors continued to serve as directors of the
Company immediately after the Annual Meeting: Randall A. Lipps,
Mark W. Parrish, Vance B. Moore, James T. Judson, Gary S.
Petersmeyer and Bruce D. Smith.
Proposal 2- Advisory Vote on Executive Compensation
The stockholders voted, on an advisory basis, to approve named
executive officer compensation by the following vote:
For
Against
Abstain
Broker Non-Votes
32,554,296
258,203
29,560
2,577,124
Proposal 3- Advisory Vote on Frequency of Solicitation of
Advisory Vote on Executive Compensation
The stockholders voted, on an advisory basis, to approve the
frequency of solicitation of advisory votes to approve named
executive officer compensation by the following vote:
1 Year
2 Years
3 Years
Abstain
Broker Non-Votes
28,102,455
27,996
4,681,116
30,492
2,577,124
Proposal 4- Ratification of the Selection of the Independent
Registered Public Accounting Firm
The stockholders ratified the selection of Deloitte Touche LLP as
the Companys independent registered public accounting firm for
the year ending December 31, 2017 by the following vote:
For
Against
Abstain
Broker Non-Votes
35,237,798
162,629
18,756


About OMNICELL, INC. (NASDAQ:OMCL)

Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.

OMNICELL, INC. (NASDAQ:OMCL) Recent Trading Information

OMNICELL, INC. (NASDAQ:OMCL) closed its last trading session up +0.40 at 41.50 with 140,574 shares trading hands.